Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc. has filed its quarterly report on Form 10‑Q with the U.S. Securities and Exchange Commission for the period ended March 31, 2026, confirming it has met all required reporting and data submission obligations over the past year. The filing classifies the company as a large accelerated filer, notes it is not a shell company, and discloses that 145,056,384 common shares were outstanding as of April 27, 2026, excluding a significant block of treasury shares, information that is relevant for investors tracking its capital structure and regulatory status.
The report includes unaudited condensed consolidated financial statements, management’s discussion and analysis of financial condition and results of operations, as well as disclosures on market risk, controls and procedures, legal proceedings, risk factors and equity transactions. The breadth of sections signals ongoing transparency around ResMed’s operational and financial position, providing stakeholders with detailed insight into performance, governance, and potential risks during the quarter.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$44.80 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. is a Delaware‑incorporated medical technology company listed on the New York Stock Exchange under the ticker RMD. It develops and sells devices and software for the diagnosis, treatment and management of sleep apnea and other chronic respiratory conditions, serving patients, providers and payers in the global respiratory care market.
Average Trading Volume: 1,311,550
Technical Sentiment Signal: Hold
Current Market Cap: A$41.48B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.